These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35165061)
1. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma. Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of Type VII Collagen during oral carcinogenesis. Poomsawat S; Kariya A; Nimmanon T; Kosanwat T; Juengsomjit R; Sirima S J Appl Oral Sci; 2023; 31():e20220486. PubMed ID: 37194793 [TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa. Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189 [TBL] [Abstract][Full Text] [Related]
5. Expression of p16 in oral cancer and premalignant lesions. Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055 [TBL] [Abstract][Full Text] [Related]
6. Histopathological assessment of oral leukoplakia. Osteonectin as possible biomarker for further diagnostics. Duś-Ilnicka I; Radwan-Oczko M; Gerber H; Hałoń A Pol J Pathol; 2020; 71(2):138-145. PubMed ID: 32729304 [TBL] [Abstract][Full Text] [Related]
7. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma. de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518 [TBL] [Abstract][Full Text] [Related]
8. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903 [TBL] [Abstract][Full Text] [Related]
9. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients. Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174 [TBL] [Abstract][Full Text] [Related]
10. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation. Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study. Gupta K; Metgud R; Gupta J J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537 [TBL] [Abstract][Full Text] [Related]
12. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia. Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma. Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235 [TBL] [Abstract][Full Text] [Related]
14. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia. Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153 [TBL] [Abstract][Full Text] [Related]
15. Increased VEGFR2 and MMP9 protein levels are associated with epithelial dysplasia grading. de Carvalho Fraga CA; Farias LC; de Oliveira MV; Domingos PL; Pereira CS; Silva TF; Roy A; Gomez RS; de Paula AM; Guimarães AL Pathol Res Pract; 2014 Dec; 210(12):959-64. PubMed ID: 25441661 [TBL] [Abstract][Full Text] [Related]
16. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study. Vijayakumar G; Narwal A; Kamboj M; Sen R Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091 [TBL] [Abstract][Full Text] [Related]
18. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis. Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760 [TBL] [Abstract][Full Text] [Related]
19. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis. de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of p-Smad3 in oral carcinogenesis. Poomsawat S; Punyasingh J; Vejchapipat P Clin Oral Investig; 2015 Apr; 19(3):613-8. PubMed ID: 25035066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]